Modalis Therapeutics Corporation (TYO:4883)

Modalis Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,575	1,883	2,933	4,936	5,421
Cash & Short-Term Investments	3,575	1,883	2,933	4,936	5,421
Cash Growth	89.86%	-35.80%	-40.58%	-8.95%	40.55%
Inventory	-	6	40	-	-
Other Current Assets	42	67	88	131	27
Total Current Assets	3,617	1,956	3,061	5,067	5,448
Property, Plant & Equipment	-	-	-	223	49
Long-Term Investments	74	69	68	73	10
Other Intangible Assets	-	-	-	705	767
Other Long-Term Assets	-	-	-	1	3
Total Assets	3,691	2,025	3,129	6,069	6,277
Accounts Payable	1	-	-	1	-
Accrued Expenses	20	91	17	25	17
Current Income Taxes Payable	95	105	123	126	39
Other Current Liabilities	1	2	1	28	2
Total Current Liabilities	117	198	141	180	58
Long-Term Debt	-	412	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	5	11
Other Long-Term Liabilities	28	36	49	335	1
Total Liabilities	145	646	190	520	70
Common Stock	1,758	1,217	2,094	2,744	2,707
Additional Paid-In Capital	3,080	2,539	3,416	4,066	4,029
Retained Earnings	-1,325	-2,410	-2,605	-1,266	-527
Comprehensive Income & Other	33	33	34	5	-2
Shareholders' Equity	3,546	1,379	2,939	5,549	6,207
Total Liabilities & Equity	3,691	2,025	3,129	6,069	6,277
Total Debt	-	412	-	-	-
Net Cash (Debt)	3,575	1,471	2,933	4,936	5,421
Net Cash Growth	143.03%	-49.85%	-40.58%	-8.95%	40.55%
Net Cash Per Share	77.50	47.50	100.77	171.67	205.73
Filing Date Shares Outstanding	73.55	33.81	30.09	29.04	28.56
Total Common Shares Outstanding	69.4	33.36	29.36	28.97	28.52
Working Capital	3,500	1,758	2,920	4,887	5,390
Book Value Per Share	51.09	41.34	100.09	191.56	217.67
Tangible Book Value	3,546	1,379	2,939	4,844	5,440
Tangible Book Value Per Share	51.09	41.34	100.09	167.22	190.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.